by The global Sperm Count Test Market is estimated to be valued at US$ 517.5 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The sperm count test market deals in diagnostics and detection of male fertility levels. Sperm count tests help analyze semen samples to determine the number of sperms and their motility. A normal sperm count ranges between 15-250 million sperm per milliliter. Low sperm count or poor sperm motility/morphology can affect fertility in men. Sperm count tests are usually the first diagnostic tests recommended by urologists and fertility specialists to evaluate male factor infertility.
Market key trends:
One of the key trends in the sperm count test market is the increasing adoption of home-use sperm test kits. Various companies offer at-home collection and analysis kits that allow customers to test their sperm at home in private, without visiting a fertility clinic or laboratory. The kits include collection and storage containers, test devices, and automated digital analysis of the semen sample. The growing availability of accurate, easy-to-use home testing solutions is expected to boost the market growth over the forecast period. Another trend is the integration of advanced technologies like AI and machine learning in sperm analysis. Some tests can automate the analysis and provide detailed metrics on dozens of sperm characteristics like count, motility, morphology etc. within a short time. This technological enhancement of tests solutions is augmenting market expansion.
Porter’s Analysis
Threat of new entrants: New players need to invest significantly in R&D to develop new sperm count test techniques and gain requisite regulatory approvals which pose as a entry barrier.
Bargaining power of buyers: Buyers have moderate bargaining power given the availability of alternatives and need for accurate diagnosis and treatment.
Bargaining power of suppliers: A few dominant players control the key material supplies like reagents and equipment required for production posing moderate supplier power.
Threat of new substitutes: Emergence of new non-invasive techniques can offer substitutes but given current level of accuracy in results, threat is low in the forecast period.
Competitive rivalry: The sperm count test market experiences moderate to high competition owing to presence of few mid-size to large players.
Key Takeaways
The global Sperm Count Test Market Share is expected to witness high growth, exhibiting a CAGR of 12% over the forecast period, due to increasing male infertility rates and rising awareness.
The North American region dominated the market owing to availability of advanced diagnostic techniques and reimbursement schemes for assisted reproductive treatments in countries like the US and Canada. Asia Pacific is anticipated to be the fastest growing region on account of rising medical tourism and technical advancements in emerging economies.
Key players operating in the Sperm Count Test Market are LLC Medical Group, Abbot Laboratories, CooperSurgical Inc., Hamilton Thorne Ltd., Medical Electronic Systems, Microptic S.L., ContraVac INC, MotilityCount Aps, DNA Diagnostics Center, Prestige Consumer Healthcare, Sandstone Diagnostics, bioMerieux SA, ASKA Pharmaceuticals, Clinical Genetics Pty Ltd, Halotech DNA, SAS MARKit, Trak Fertility, UEBE Medical GmbH, Vitrolife.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc.
